Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease

Eric J Lawitz

Division of Gastroenterology

Press/Media: Press / Media

Period	Apr 24 2015 → Apr 25 2015

Media coverage

65

Media coverage

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Red Orbit
Country	United States
Date	4/25/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Morningstar.com
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Financial Content
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	SearchBug
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Industrial Info Financials
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Town Hall
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	BioSpace
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	RCL Advisors
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Franklin Credit Management Corporation
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Reliance Trust
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Market Pulse Navigator
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WorldNetDaily
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Marketplace
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Fat Pitch Financials
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Crawford Financial Planning
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	CEOWorld Magazine
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Wall Street Business Network
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Financial Content
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	TickerTech.com
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Tamar Securities
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational
Media name/outlet Finwin
Country United States
Date 4/24/15
Persons Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	TradingCharts.com
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Good Day Sacramento
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Stock Nod
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Ask.com
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KiiiTV3.com
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KATV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	CW Richmond WUPV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KMEG 14
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	MyFoxTallahassee.com
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	FOX 14 TV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KTUL
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KXNet.com
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KAUZ
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KSWO
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	35 WSEE
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KCEN HD
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KMPH Fox 26
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Nebraska TV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KYTX CBS 19
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	12 News Now
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Kuam News 8
Country	Guam
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	GTN News
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KFMB-TV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	News 9
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	ABC News 4 Charleston
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	Fox41.com
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WCAX TV3
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KPTM FOX 42
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WBOY
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WBOC TV 16
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KUSI.com
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KRHD TV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KPLC TV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WVNS
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WXTX Fox 54
Country	Georgia
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WSET
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WLTZ 38
Country	Georgia
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	AZ-TV7
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WAND TV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KNDO KNDU
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	ABC 3340
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WTRF
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	KSTC-TV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz

Title	Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Media name/outlet	WSFX-TV
Country	United States
Date	4/24/15
Persons	Eric J Lawitz